StockData
Pulmatrix, Inc. logo

Pulmatrix, Inc. (PULM) stock

PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.37+0.04 (+3.01%)

Close on Nov 17, 2026Market cap $5.00MP/E –Yield –

Pulmatrix operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Pulmatrix's operating cash flow for the twelve months ending Sep 30, 2026 was -$3.65M. For fiscal 2025 it was -$5.43M. The highest annual figure on record is $3.23M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.43M–
FY2024Dec 31, 2024-$10.72M–
FY2023Dec 31, 2023-$15.99M–
FY2022Dec 31, 2022-$19.36M–
FY2021Dec 31, 2021-$19.73M–
FY2020Dec 31, 2020-$12.48M-486.5%
FY2019Dec 31, 2019$3.23M–
FY2018Dec 31, 2018-$16.76M–
FY2017Dec 31, 2017-$14.48M–
FY2016Dec 31, 2016-$13.24M–
FY2015Dec 31, 2015-$12.47M–
FY2014Dec 31, 2014-$9.17M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$770.00K–
Q2 FY2026Jun 30, 2026-$1.11M–
Q1 FY2026Mar 31, 2026-$1.07M–
Q4 FY2025Dec 31, 2025-$706.00K–
Q3 FY2025Sep 30, 2025-$1.03M–
Q2 FY2025Jun 30, 2025-$1.88M–
Q1 FY2025Mar 31, 2025-$1.81M–
Q4 FY2024Dec 31, 2024-$1.26M–
Q3 FY2024Sep 30, 2024-$3.06M–
Q2 FY2024Jun 30, 2024-$3.68M–
Q1 FY2024Mar 31, 2024-$2.72M–
Q4 FY2023Dec 31, 2023-$2.01M–
Q3 FY2023Sep 30, 2023-$4.14M–
Q2 FY2023Jun 30, 2023-$4.90M–
Q1 FY2023Mar 31, 2023-$4.93M–
Q4 FY2022Dec 31, 2022-$5.05M–
Q3 FY2022Sep 30, 2022-$3.60M–
Q2 FY2022Jun 30, 2022-$4.56M–
Q1 FY2022Mar 31, 2022-$6.14M–
Q4 FY2021Dec 31, 2021-$4.40M–
Q3 FY2021Sep 30, 2021-$3.31M–
Q2 FY2021Jun 30, 2021-$6.52M–
Q1 FY2021Mar 31, 2021-$5.50M-788.6%
Q4 FY2020Dec 31, 2020-$2.77M–
Q3 FY2020Sep 30, 2020-$5.52M–
Q2 FY2020Jun 30, 2020-$5.00M-133.2%
Q1 FY2020Mar 31, 2020$798.00K–
Q4 FY2019Dec 31, 2019-$4.43M–
Q3 FY2019Sep 30, 2019-$3.93M–
Q2 FY2019Jun 30, 2019$15.05M–
Q1 FY2019Mar 31, 2019-$3.46M–
Q4 FY2018Dec 31, 2018-$4.17M–
Q3 FY2018Sep 30, 2018-$4.52M–
Q2 FY2018Jun 30, 2018-$4.95M–
Q1 FY2018Mar 31, 2018-$3.13M–
Q4 FY2017Dec 31, 2017-$3.21M–
Q3 FY2017Sep 30, 2017-$4.62M–
Q2 FY2017Jun 30, 2017-$3.66M–
Q1 FY2017Mar 31, 2017-$2.99M–
Q4 FY2016Dec 31, 2016-$2.50M–

More Pulmatrix figures

See a number that looks wrong?